- Research Grants
Daniel de Almeida Rocha Valente in research grants and scholarships supported by FAPESP.
Compounds that act as agonists for Toll-like receptors (TLRs) are considered promising candidates for drug development against cancer, including bladder cancer non-muscle invasive (BCNMI). In this context, the alternative treatments that reduce rates of recurrence, progression, and its impact on clinical outcomes of patients with BCNMI the combination of immunotherapy with P-MAP and inh...
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)